Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) Return on Capital Employed (2020 - 2025)

Historic Return on Capital Employed for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 0.13%.

  • Strata Critical Medical's Return on Capital Employed rose 1200.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.13% for FY2024, which is 1100.0% up from last year.
  • As of Q3 2025, Strata Critical Medical's Return on Capital Employed stood at 0.13%, which was up 1200.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Return on Capital Employed ranged from a high of 0.02% in Q1 2021 and a low of 0.26% during Q2 2024
  • Over the past 5 years, Strata Critical Medical's median Return on Capital Employed value was 0.18% (recorded in 2023), while the average stood at 0.16%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -1100bps in 2022, then surged by 1200bps in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Return on Capital Employed stood at 0.1% in 2021, then crashed by -81bps to 0.18% in 2022, then plummeted by -41bps to 0.25% in 2023, then increased by 25bps to 0.19% in 2024, then grew by 30bps to 0.13% in 2025.
  • Its Return on Capital Employed was 0.13% in Q3 2025, compared to 0.16% in Q2 2025 and 0.19% in Q1 2025.